Inhibrx Biosciences, Inc. (INBX)
NASDAQ · Healthcare
Inhibrx Biosciences, Inc. annual/quarterly shareholder equity history from 2023 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Inhibrx Biosciences, Inc. shareholder equity for the quarter ending December 31, 2025 were 8.0M, a 94.02% decrease year-over-year.
- Inhibrx Biosciences, Inc. shareholder equity for 2025 were 8.0M, a 94.02% decrease from 2024.
- Inhibrx Biosciences, Inc. shareholder equity for 2024 were 133.6M, a 207.07% increase from 2023.
- Inhibrx Biosciences, Inc. shareholder equity for 2023 were 43.5M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Inhibrx Biosciences, Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $8 |
| 2024 | $134 |
| 2023 | $44 |
| Inhibrx Biosciences, Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2025-12-31 | $8 |
| 2024-12-31 | $134 |
| 2023-12-31 | $44 |
Inhibrx Biosciences, Inc. Shareholder Equity — FAQ
Inhibrx Biosciences, Inc. (INBX) shareholder equity over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see INBX's shareholder equity history?
The chart and table above show Inhibrx Biosciences, Inc.'s shareholder equity by year and by quarter, including the growth rate.